| Application of 3D tumoroid systems to define immune and cytotoxic therapeutic responses based on tumoroid and tissue slice culture molecular signatures NK Finnberg, P Gokare, A Lev, SI Grivennikov, AW MacFarlane IV, ... Oncotarget 8 (40), 66747, 2017 | 118 | 2017 |
| Current treatment of early breast cancer: adjuvant and neoadjuvant therapy E Miller, HJ Lee, A Lulla, L Hernandez, P Gokare, B Lim F1000Research 3, 2014 | 107 | 2014 |
| Sorafenib and quinacrine target anti-apoptotic protein MCL1: a poor prognostic marker in anaplastic thyroid cancer (ATC) J Abdulghani, P Gokare, JN Gallant, D Dicker, T Whitcomb, T Cooper, ... Clinical Cancer Research 22 (24), 6192-6203, 2016 | 41 | 2016 |
| Inducible de novo expression of neoantigens in tumor cells and mice Nature Biotechnology, 2020 | 38* | 2020 |
| P53 represses pyrimidine catabolic gene dihydropyrimidine dehydrogenase (DPYD) expression in response to thymidylate synthase (TS) targeting P Gokare, NK Finnberg, PH Abbosh, J Dai, ME Murphy, WS El-Deiry Scientific Reports 7 (1), 9711, 2017 | 28 | 2017 |
| Agonists of the TRAIL death receptor DR5 sensitize intestinal stem cells to chemotherapy-induced cell death and trigger gastrointestinal toxicity NK Finnberg, P Gokare, A Navaraj, KA Lang Kuhs, G Cerniglia, H Yagita, ... Cancer research 76 (3), 700-712, 2016 | 19 | 2016 |
| PIGN gene expression aberration is associated with genomic instability and leukemic progression in acute myeloid leukemia with myelodysplastic features EK Teye, A Sido, P Xin, NK Finnberg, P Gokare, YI Kawasawa, ... Oncotarget 8 (18), 29887, 2017 | 13 | 2017 |
| Novel and emerging targeted therapies of colorectal cancer N Finnberg, P Gokare, W S El-Deiry Current Clinical Pharmacology 10 (4), 279-298, 2015 | 6 | 2015 |
| Targeting of Chk2 as a countermeasure to dose-limiting toxicity triggered by topoisomerase-II (TOP2) poisons P Gokare, A Navaraj, S Zhang, N Motoyama, SS Sung, NK Finnberg Oncotarget 7 (20), 29520, 2016 | 5 | 2016 |
| Bcl-2 Protein Targeting by the p53/p21 Complex LJ Hernandez Borrero, R Sikder, A Lulla, P Gokare, PR Del Valle, X Tian, ... Cancer Research 78 (10), 2770-2771, 2018 | 4 | 2018 |
| MMR-deficiency and BRCA2/EGFR/NTRK mutations P Gokare, AR Lulla, WS El-Deiry Aging (Albany NY) 9 (8), 1849, 2017 | 4 | 2017 |
| Current treatment of early breast cancer: adjuvant and neoadjuvant therapy. F1000Research, 3, 198 E Miller, HJ Lee, A Lulla, L Hernandez, P Gokare, B Lim | 4 | 2014 |
| Transcription factor expression repertoire basis for epigenetic and transcriptional subtypes of colorectal cancers YR Bhandari, V Krishna, R Powers, S Parmar, SJ Thursby, E Gupta, ... Proceedings of the National Academy of Sciences 120 (31), e2301536120, 2023 | 1 | 2023 |
| The tuberous sclerosis complex gets fatter P Gokare, WS El-Deiry Oncotarget 8 (26), 41780, 2017 | 1 | 2017 |
| DR5-targeting sensitizes Lgr5+ stem cells to p53 and Chk2-dependent chemotherapy-induced cell death and produces dose-limiting gastrointestinal toxicity (GIT) NK Finnberg, P Gokare, A Navaraj, KA Lang Kuhs, G Cerniglia, H Yagita, ... Cancer Research 75 (15_Supplement), 2926-2926, 2015 | 1 | 2015 |
| Development of organoids-bacteria co-cultures for medium-to-high throughput screening E Valle-Encinas, M Doorn, F Pourfarzad, LS Mateo, P Gokare, D Pocalyko, ... Cancer Research 84 (6_Supplement), 242-242, 2024 | | 2024 |
| Development of a medium-to-high throughput organoid-bacteria co-culture platform for the assessment of host pathogen interaction E Valle-Encinas, R Nair, K Pisa, M Doorn, F Pourfarzad, LS Mateo, ... Cancer Research 83 (7_Supplement), 5917-5917, 2023 | | 2023 |
| Identification of therapeutic vulnerabilities by genome-wide CRISPR knockout library screening of colon cancer organoids PJ Buckhaults, S Khalili, C Banister, PR Gokare, D Pocalyko, K Bachman Cancer Research 83 (7_Supplement), 251-251, 2023 | | 2023 |
| Abstract A012: Transcription factor expression repertoire basis for epigenetic and transcriptional subtypes of colorectal cancers YR Bhandari, V Krishna, R Powers, S Parmar, SJ Thursby, E Gupta, ... Cancer Research 82 (23_Supplement_2), A012-A012, 2022 | | 2022 |
| Aurora kinase is synthetic lethal with APC loss of function in engineered human colon organoid models DS Gaffney, E Vesely, D Pocalyko, K Bachman, K Wiehagen, G Cowley, ... Cancer Research 82 (12_Supplement), 1416-1416, 2022 | | 2022 |
Niklas FinnbergProPharma Group SwedenVerified email at propharmagroup.com
